Drug Shortage Report for DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, USP
Report ID | 174351 |
Drug Identification Number | 02369567 |
Brand name | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION |
Common or Proper name | DIPHENHYDRAMINE HYDROCHLORIDE INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | DIPHENHYDRAMINE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1 mL |
ATC code | R06AA |
ATC description | ANTIHISTAMINES FOR SYSTEMIC USE |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-11-01 |
Estimated end date | 2023-02-28 |
Actual end date | 2023-02-28 |
Shortage status | Resolved |
Updated date | 2023-03-01 |
Company comments | Product is on 100% allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-03-01 | French | Compare |
v5 | 2023-03-01 | English | Compare |
v4 | 2023-01-02 | French | Compare |
v3 | 2023-01-02 | English | Compare |
v2 | 2022-11-11 | French | Compare |
v1 | 2022-11-11 | English | Compare |
Showing 1 to 6 of 6